Literature DB >> 21944360

Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function.

Susan Eagle1, Colleen M Brophy, Padmini Komalavilas, Kyle Hocking, Gowthami Putumbaka, Michael Osgood, Kevin Sexton, Marzia Leacche, Joyce Cheung-Flynn.   

Abstract

Marking human saphenous vein graft (HSV) with a surgical skin marker to prevent twisting on implantation is a common practice in peripheral and coronary artery bypass procedures. This study is designed to examine the effects of surgical skin markers on the HSV smooth muscle and endothelial functional responses. De-identified HSV remnants were collected during peripheral and coronary artery bypass procedures. Physiologic responses of the HSV were measured using a muscle bath. Veins that were marked with surgical skin markers intraoperatively generated significantly less contractile force to depolarizing KCl (110 mM) and receptor-mediated contractile agonists than unmarked HSV, suggesting that surgical skin markers impaired HSV smooth muscle contractility. To directly access the effects of chemical components in the surgical skin markers, unmarked HSV was exposed to isopropyl alcohol (a solvent commonly used in surgical skin markers) or methylene blue (a dye). Smooth muscle contractility was significantly reduced by isopropyl alcohol and methylene blue. Endothelial-dependent relaxation to carbachol was significantly reduced after exposure to surgical skin markers. Our data demonstrated that marking HSV with surgical skin markers reduces smooth muscle and endothelial functional viability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944360      PMCID: PMC3957273     

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  35 in total

1.  Saphenous vein grafts: to use or not to use?

Authors:  Shahzad Gull Raja; Zulfiqar Haider; Mukhtar Ahmad; Haider Zaman
Journal:  Heart Lung Circ       Date:  2004-12       Impact factor: 2.975

2.  Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.

Authors:  William W Chu; Seung-Woon Rha; Pramod K Kuchulakanti; Edouard Cheneau; Rebecca Torguson; Ellen Pinnow; Jana Alexieva-Fournadjiev; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Ron Waksman
Journal:  Am J Cardiol       Date:  2005-11-02       Impact factor: 2.778

3.  [Assessment of saphenous vein graft wall characteristics with intravascular ultrasound imaging].

Authors:  T Kobayashi; H Makuuchi; Y Naruse; T Sato; T Fujiki; M Ninomiya; K Ogata; N Komiyama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

4.  Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.

Authors:  Abdul R Halabi; John H Alexander; Linda K Shaw; Todd J Lorenz; Lawrence Liao; David F Kong; Carmelo A Milano; Robert A Harrington; Peter K Smith
Journal:  Am J Cardiol       Date:  2005-09-06       Impact factor: 2.778

5.  Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats.

Authors:  R A Khalil; J K Crews; J Novak; S Kassab; J P Granger
Journal:  Hypertension       Date:  1998-05       Impact factor: 10.190

6.  Early angiographic control of perioperative ischemia after coronary artery bypass grafting.

Authors:  A M Fabricius; W Gerber; M Hanke; J Garbade; R Autschbach; F W Mohr
Journal:  Eur J Cardiothorac Surg       Date:  2001-06       Impact factor: 4.191

7.  Length-tension relationship of smooth muscle of the hog carotid artery.

Authors:  J T Herlihy; R A Murphy
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

8.  Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass.

Authors:  Robert Poston; Junyan Gu; James Brown; James Gammie; Charles White; Jeffrey Manchio; Richard N Pierson; Bartley P Griffith; Paul Gurbel; Udaya Tandry; Timothy B Gilbert
Journal:  J Cardiothorac Vasc Anesth       Date:  2005-02       Impact factor: 2.628

Review 9.  Isopropanol: summary of TSCA test rule studies and relevance to hazard identification.

Authors:  R W Kapp; C Bevan; T H Gardiner; M I Banton; T R Tyler; G A Wright
Journal:  Regul Toxicol Pharmacol       Date:  1996-06       Impact factor: 3.271

10.  Influence of perioperative storage solutions on long-term vein graft function and morphology.

Authors:  M G Davies; P O Hagen
Journal:  Ann Vasc Surg       Date:  1994-03       Impact factor: 1.466

View more
  18 in total

1.  Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue.

Authors:  Shinsuke Kikuchi; Richard D Kenagy; Lu Gao; Thomas N Wight; Nobuyoshi Azuma; Michael Sobel; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2015-04-30       Impact factor: 4.268

2.  Pressure control during preparation of saphenous veins.

Authors:  Fan Dong Li; Susan Eagle; Colleen Brophy; Kyle M Hocking; Michael Osgood; Padmini Komalavilas; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

3.  Adenosine triphosphate as a molecular mediator of the vascular response to injury.

Authors:  Christy M Guth; Weifung Luo; Olukemi Jolayemi; Kalyan S Chadalavada; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

4.  Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.

Authors:  Igor V Voskresensky; Eric S Wise; Kyle M Hocking; Fan Dong Li; Michael J Osgood; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-11       Impact factor: 14.766

5.  Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.

Authors:  Michael J Osgood; Kevin Sexton; Igor Voskresensky; Kyle Hocking; Jun Song; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  J Vasc Surg       Date:  2016-08       Impact factor: 4.268

6.  Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.

Authors:  Kyle M Hocking; Weifeng Luo; Fan Dong Li; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  J Vasc Surg       Date:  2015-02-19       Impact factor: 4.268

7.  Intimal thickness associated with endothelial dysfunction in human vein grafts.

Authors:  Fan Dong Li; Kevin W Sexton; Kyle M Hocking; Michael J Osgood; Susan Eagle; Joyce Cheung-Flynn; Colleen M Brophy; Padmini Komalavilas
Journal:  J Surg Res       Date:  2012-06-23       Impact factor: 2.192

8.  Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Authors:  Michael J Osgood; Kyle M Hocking; Igor V Voskresensky; Fan Dong Li; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2013-07-30       Impact factor: 4.268

9.  Traditional graft preparation decreases physiologic responses, diminishes viscoelasticity, and reduces cellular viability of the conduit: A porcine saphenous vein model.

Authors:  Eric S Wise; Kyle M Hocking; Weifeng Luo; Daniel L Feldman; Jun Song; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Vasc Med       Date:  2016-05-23       Impact factor: 3.239

10.  Relaxin treatment reverses insulin resistance in mice fed a high-fat diet.

Authors:  Jeffrey S Bonner; Louise Lantier; Kyle M Hocking; Li Kang; Mark Owolabi; Freyja D James; Deanna P Bracy; Colleen M Brophy; David H Wasserman
Journal:  Diabetes       Date:  2013-06-25       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.